Schedule 13D ownership disclosure

Ra Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 74933V108

Event date: 2016-10-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,745,846
Percent of class
12.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-16-131830
Form type
SC 13D
Filer
MORGENTHALER VENTURE PARTNERS IX LP
CIK
CIK 1439101
Filed
Nov 07, 2016
Reporting period
Oct 25, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub